BioCryst R&D chief granted options and RSUs
BioCryst Pharmaceuticals Chief R&D Officer Sandeep Menon received equity grants as part of his compensation.
Rhea-AI Filing Summary
BioCryst Pharmaceuticals Chief R&D Officer Sandeep Menon received equity grants as part of his compensation. On April 6, 2026, he was granted 441,350 employee stock options for common stock at an exercise price of $9.47 per share, expiring in 2036.
He also received an inducement grant of 205,150 restricted stock units of common stock. Both the RSUs and the options vest or become exercisable in equal 25% installments on each of the first, second, third and fourth anniversaries of the grant date, aligning his incentives with longer-term company performance rather than reflecting open-market trading.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 646,500 shares
Grant/Award
2 txns
Insider
Menon Sandeep
Role
Chief R&D Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Emp. Stock Option (Right to Buy) | 441,350 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 205,150 | $0.00 | $0.00 |
Holdings After Transaction:
Emp. Stock Option (Right to Buy) — 441,350 contracts (Direct);
Common Stock — 205,150 shares (Direct)
Footnotes (2)
- F1. Inducement grant of restricted stock units pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated (the "Stock Incentive Plan"), which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
- F2. Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.
Key Figures
Employee stock options granted: 441,350 options
Option exercise price: $9.47/share
Option expiration: April 6, 2036
+2 more
5 metrics
Employee stock options granted
441,350 options
Granted April 6, 2026 to Chief R&D Officer
Option exercise price
$9.47/share
Exercise price for 441,350 employee stock options
Option expiration
April 6, 2036
Expiration date of employee stock options
Restricted stock units granted
205,150 RSUs
Inducement grant of common stock RSUs
Vesting schedule
25% per year over 4 years
Applies to both RSUs and stock options
Key Terms
restricted stock units, employee stock options, Stock Incentive Plan, inducement grant
4 terms
restricted stock units financial
"Inducement grant of restricted stock units pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
employee stock options financial
"Inducement grant of employee stock options pursuant to the Stock Incentive Plan"
Employee stock options are contracts that give workers the right to buy a company's shares at a set price sometime in the future, like a coupon that lets you purchase stock at today’s price later on. Investors care because they align employees’ incentives with company performance and create a potential future claim on shares that can reduce existing owners’ percentage and add to a company’s reported compensation costs.
Stock Incentive Plan financial
"pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan, as amended and restated"
A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.
inducement grant financial
"Inducement grant of employee stock options pursuant to the Stock Incentive Plan"
An inducement grant is a stock-based reward given to a new hire—often options or restricted shares—used as a recruiting “signing bonus” to encourage someone to join a company and stay long enough to add value. Investors care because these grants can dilute existing shareholdings, change executive incentives and increase reported compensation costs, so they signal both management priorities and potential impacts on shareholder value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did BioCryst (BCRX) Chief R&D Officer Sandeep Menon receive in this Form 4?
He received equity compensation grants, not open-market purchases. The filing shows 441,350 employee stock options at a $9.47 exercise price and 205,150 restricted stock units, all tied to BioCryst common stock and vesting over four years as part of his inducement package.
How many BioCryst (BCRX) stock options were granted to Sandeep Menon?
He was granted 441,350 employee stock options. These options give him the right to buy BioCryst common stock at $9.47 per share and expire in 2036, with 25% of the options becoming exercisable on each anniversary from the first through fourth years.
What restricted stock units did Sandeep Menon receive from BioCryst (BCRX)?
He received an inducement grant of 205,150 restricted stock units of common stock. These RSUs vest 25% on each of the first, second, third and fourth anniversaries of the grant date, effectively spreading the ownership benefits across a four-year service period.
Why are these BioCryst (BCRX) grants described as inducement awards?
They are characterized as inducement grants under the company’s Stock Incentive Plan. The footnotes state the RSUs and employee stock options were granted pursuant to BioCryst’s Stock Incentive Plan and structured to vest annually over four years, supporting executive recruitment and retention objectives.
AI-generated analysis. How Rhea-AI works. Not financial advice.
